Commonwealth of Australia Explanatory Memoranda

[Index] [Search] [Download] [Bill] [Help]


NATIONAL HEALTH AMENDMENT (DECISIONS UNDER THE CONTINENCE AIDS PAYMENT SCHEME) BILL 2021

                              2019-2020-2021



  THE PARLIAMENT OF THE COMMONWEALTH OF AUSTRALIA




                                 SENATE




  NATIONAL HEALTH AMENDMENT (DECISIONS UNDER THE
      CONTINENCE AIDS PAYMENT SCHEME) BILL 2021




                   EXPLANATORY MEMORANDUM




(Circulated by authority of the Minister for Senior Australians and Aged Care
                    Services, the Hon Richard Colbeck)


NATIONAL HEALTH AMENDMENT (DECISIONS UNDER THE CONTINENCE AIDS PAYMENT SCHEME) BILL 2021 OUTLINE Purpose of the Bill The purpose of the National Health Amendment (Decisions under the Continence Aids Payment Scheme) Bill 2021 (the Bill) is to provide express support for the Continence Aids Payment Scheme (CAPS) to confer review functions on the Administrative Appeals Tribunal (AAT). Objective of the Bill The Bill amends the Act to provide that a legislative instrument made under section 12 of the Act may provide that applications may be made to the AAT for review of decisions made in exercise of powers conferred by the instrument. Overview of the Bill The Bill amends the National Health Act 1953 (the Act) to provide that the Minister may, by legislative instrument, formulate a Continence Aids Payment Scheme, under which the Commonwealth makes payments as a contribution towards the cost of buying products that help manage incontinence. The CAPS is currently formulated in the Continence Aids Payment Scheme 2020 (CAPS Instrument). Under the CAPS, an annual or six monthly payment is available to people five years of age and over who suffer from permanent and severe incontinence caused by particular kinds of conditions specified in the CAPS Instrument and who meet other eligibility criteria (a participating person). The payments help offset the costs of purchasing continence products from the participating person's supplier of choice. The Act provides at section 14 and 15 for AAT review of certain eligibility decisions of the Chief Executive Medicare (CEM) under the CAPS Scheme. However, the CAPS Instrument provides for other decisions relevant to the operation of the Scheme that are not covered by sections 14 and 15, including certain decisions made by the Secretary of the Department relating to the representation of a participating person by another individual or organisation, for the purposes of the CAPS. On 16 January 2021 the CAPS Instrument was amended to provide that persons and organisations affected by these decisions of the Secretary could apply for internal merits review or, following internal review, independent merits review of that initial review decision by the AAT. The Bill amends the Act to make it clear on the face of the Act that the legislative instrument establishing the CAPS can provide for AAT review of decisions provided for in the instrument, and that are not already covered by sections 14 or 15 of the Act. The independent merits review of decisions accords with good administrative law principles. 1


Financial Impact Statement There is no associated financial impact as a result of the Bill. 2


Statement of Compatibility with Human Rights Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011 NATIONAL HEALTH AMENDMENT (DECISIONS UNDER THE CONTIENCE AIDS PAYMENT SCHEME) BILL 2021 This Bill is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011. Overview of the Bill The purpose of the National Health Amendment (Decisions under the Continence Aids Payment Scheme) Bill 2021 (the Bill) is to expressly provide for the Continence Aids Payment Scheme to confer review functions on the Administrative Appeals Tribunal (AAT). The Bill amends the National Health Act 1953 (the Act) to provide that the legislative instrument made under section 12 of the Act establishing the Continence Aids Payment Scheme (CAPS) may provide applications to be made to the AAT for review of decisions made under the instrument. The CAPS is currently formulated in the Continence Aids Payment Scheme 2020 (CAPS Instrument). Under the CAPS, an annual or six monthly payment is available to people five years of age and over who suffer from permanent and severe incontinence caused by particular kinds of conditions specified in the CAPS Instrument and who meet other eligibility criteria (a participating person). The payments help offset the costs of purchasing continence products from the participating person's supplier of choice. The Act provides at section 14 and 15 for AAT review of certain eligibility decisions of the Chief Executive Medicare (CEM) under the CAPS. However, the CAPS Instrument provides for other decisions relevant to the operation of the Scheme that are not covered by sections 14 and 15, including certain decisions made by the Secretary of the Department under sections 21 and 22 relating to the representation of a participating person by another individual or organisation for the purposes of the CAPS. Section 21 of the CAPS Instrument give the Secretary of the Department power to approve an individual to represent a participating person who is an assisted person or a minor, or to revoke such an approval. Section 22 of the CAPS Instrument gives the Secretary power to direct the Chief Executive Medicare to decline to make a payment under the CAPS Scheme to an organisation who has been authorised to receive payments on behalf of a participating person. The Secretary will action these powers where the Secretary is satisfied that the arrangement for the payment is not operating to the benefit of the participating person or where the organisation has not complied with any obligation under the CAPS in respect of the participating person. These obligations include assisting participating persons to obtain continence aids appropriate to their needs and informing participating persons of any unused CAPS payments 30 days before the end of the financial year to which the payment relates. 3


On 16 January 2021, the CAPS Instrument was amended to enable affected by decisions made by the Secretary to apply for internal merits review or, following internal review, independent merits review by the AAT. The Bill amends the Act to expressly provide for the CAPS Instrument to refer decisions made under the Instrument for independent merits review by the AAT. Human rights implications As set out above, the amendments to the Act are limited to conferring review functions on the AAT for certain decisions made under the CAPS Instrument. To this extent, the amendments do not themselves directly engage human rights. However, to the extent that decisions under sections 21 and 22 of the CAPS Instrument may have an effect on a participating person under the CAPS, the amendments made by the Bill may engage:  the right to equality and non-discrimination contained in Article 2(2) of the International Covenant on Economic, Social and Cultural Rights (ICESCR) and the right to health contained in Article 12 of that covenant, and  the rights of people with disabilities in the Covenant on the Rights of Persons with Disabilities, especially articles 3(b) and 4 which require Parties to ensure and promote the full realisation of all human rights and fundamental freedoms for all persons with disabilities without discrimination of any kind on the basis of disability. The CAPS Instrument contributes towards the realisation of rights contained in articles 11 and 12 of the ICESCR, specifically the right of everyone to an adequate standard of living and to the enjoyment of the highest attainable standard of physical and mental health. The amendments in this Bill further contribute to the realisation of these rights, as providing for independent review of decisions will provide a safeguard for participating persons where decisions under sections 21 and 22 of the CAPS Instrument may affect them. Conclusion The amendments to the Bill are compatible with human rights as it further promotes the realisation of relevant rights and, to the extent that the Instrument generally operates to limit the right to equality and non-discrimination, that limitation is reasonable, necessary and proportionate. Senator the Hon Richard Colbeck, Minister for Senior Australians and Aged Care Services 4


NATIONAL HEALTH AMENDMENT (DECISIONS UNDER THE CONTINENCE AIDS PAYMENT SCHEME) BILL 2021 NOTES ON CLAUSES Clause 1 - Short Title Clause 1 provides that the Bill, when enacted, may be cited as the National Health Amendment (Decisions under the Continence Aids Payment Scheme) Act 2021 (the Amending Act). Clause 2 - Commencement This clause provides the Amending Act will commence the day after it receives the Royal Assent. Clause 3 - Schedules This clause provides that each piece of legislation that is specified in a Schedule to the Amending Act is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item has effect according to its terms. This is a technical provision which gives operational effect to the amendments contained in the Schedules. SCHEDULE 1 - AMENDMENTS National Health Act 1953 Item 1 - At the end of section 12 This item adds a new subsection 12(4) to the Act which provides that without limiting subsection 12(1) the legislative instrument made under subsection 12(1) may provide for applications to be made to the AAT for decision made under the instrument. Section 21 of the CAPS Instrument give the Secretary of the Department power to approve an individual to represent a participating person who is an assisted person or a minor, or to revoke such an approval. Section 22 of the CAPS Instrument gives the Secretary power to direct the Chief Executive Medicare (CEM) to decline to make a payment under the CAPS to an organisation who has been authorised to receive payments on behalf of a participating person, where the Secretary is satisfied that the arrangement for the payment is not operating to the benefit of the participating person or that the organisation has not complied with any obligation under the CAPS in respect of any participating person. These obligations include assisting participating persons to obtain continence aids appropriate to their needs and informing participating persons of any unused CAPS payments 30 days before the end of the financial year to which the payment relates. On 16 January 2021, the CAPS Instrument was amended to provide that persons affected by these decisions could apply for internal merits review or, following internal merits review, independent merits review of the decision by the AAT. Item 1 also adds a new subsection 12(5) providing that subsections 14(5) and 15(5) of the Act do not, by implication, limit the new subsection 12(4). Subsection 14(5) and 5


15(5) of the Act provide for independent merits review of certain decisions made by the CEM about eligibility for the CAPS. Item 2 - Validation This item provides that the Continence Aids Payment Scheme Amendment (Merits Review) Instrument 2020, which amended the CAPS Instrument to provide for AAT review of decisions of the Secretary of the Department under sections 21 or 22 of the Instrument, is as valid, and is taken always to have been as valid, as it would have been if the amendment of the Act made by this Schedule had been in force when the Continence Aids Payment Scheme Amendment (Merits Review) Instrument 2020 was made. This item is included to ensure, for the avoidance of doubt, the validity of the conferral of AAT review functions under the CAPS Instrument before these amendments. 6


 


[Index] [Search] [Download] [Bill] [Help]